Dr. Boobalan Pachaiyappan
Recent Articles
Maryland Biotech Gains Regulatory Approval 12/26/2024
Gain Therapeutics Inc. (GANX:NASDAQ) recently received Australian regulatory approval to begin GT-02287 evaluation in Parkinson's disease (PD) patients.
Due to permission requirements, not all quotes are shown.
